# PeptidePal vs Ascend

The clearest difference is review sentiment: Ascend at 80% against PeptidePal's 33%. Ascend also leads on rating (4.6 vs 3.4) and ratings volume (55 vs 5). PeptidePal's advantage is iOS requirement (15.1 vs 17.0). On price, ads, in-app purchases and monetization model there is nothing between them.

Both are free to download. PeptidePal sells 3 in-app purchases, starting at $2.99 per month and Ascend sells 3 in-app purchases, starting at $9.99 per month. Whichever you choose, the download price is not the number that matters.

Ascend holds the better App Store score, 4.6 against 3.4. That said, the two scores are not equally well evidenced: Ascend has 55 ratings behind it against 5, so its average is the more settled of the two. Written reviews point the same way: 33% of PeptidePal's written reviews are positive against 80% of Ascend's.

PeptidePal ships an update fortnightly, Ascend weekly. Both last shipped on October 24, 2026.

## The numbers

| Metric | PeptidePal | Ascend |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [3.4 (5 ratings)](https://appshunter.io/ios/app/peptidepal/id6746348113/reviews) | **[4.6 (55 ratings)](https://appshunter.io/ios/app/ascend-peptide-tracker/id6755852284/reviews)** |
| Number of ratings | 5 | **55** |
| Positive reviews | 33.3% of reviews | **80.0% of reviews** |
| In-app purchases | Yes | Yes |
| Ads | No | No |
| Update frequency | Fortnightly | **Weekly** |
| Monetization | Freemium | Freemium |
| Size | 49 MB | 311 MB |
| Requires iOS | **15.1** | 17.0 |
| Devices | **iPhone, iPod** | iPhone |
| Age rating | 17+ | 12+ |
| Developer | [SIGNALWORKS LABS INC.](https://appshunter.io/developer/1816293557) | [Michael Zhu](https://appshunter.io/developer/1856720667) |

## What reviewers say

### PeptidePal

[App page](https://appshunter.io/ios/app/peptidepal/id6746348113)

This app helps users meticulously track research peptides, manage inventory, and schedule doses with smart reminders. It also offers new health tracking features for sleep, supplements, and progress monitoring, with secure data syncing and export options.

**Highlights:** Log doses with a simple swipe, Track multiple peptides simultaneously, Organize peptide stock with low stock alerts, Daily or specific day dose reminders, Monitor sleep patterns and quality, Track weight and body measurements, Export data as CSV for analysis

**In-app purchases (3)**

| Purchase | Price | Billing |
| --- | --- | --- |
| PeptidePal Pro | $2.99 | per month |
| Peptidepal Yearly | $29.99 | per year |
| PeptidePal Pro | $2.99 | one-time |


### Ascend

[App page](https://appshunter.io/ios/app/ascend-peptide-tracker/id6755852284)

This app helps users track their peptide usage, including specific compounds like Retatrutide and Ozempic. It offers features for logging doses, managing side effects, and monitoring nutrition, providing a centralized platform for peptide journey management.

**Highlights:** All-in-one peptide journey tracking, Smart AI-powered food logging, Dose reconstitution calculator, Peptide library with detailed info, Side effect management, Dose reminders

**In-app purchases (3)**

| Purchase | Price | Billing |
| --- | --- | --- |
| Ascend | $9.99 | per month |
| Ascend | $29.99 | per year |
| Unlimited | $39.99 | per year |


## Frequently asked questions

### Is PeptidePal free?

PeptidePal is free to download, with in-app purchases available.

### Is Ascend free?

Ascend is free to download, with in-app purchases available.

### Which has better reviews, PeptidePal or Ascend?

Ascend is rated higher. PeptidePal averages 3.4 out of 5 from 5 ratings, while Ascend averages 4.6 from 55 ratings.

### Do PeptidePal or Ascend have ads?

Neither PeptidePal nor Ascend shows ads.

### Which is updated more often, PeptidePal or Ascend?

PeptidePal ships an update fortnightly, and Ascend weekly. Most recently, PeptidePal was updated on October 24, 2026 and Ascend on October 24, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*